Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
3,177 people get MAKO articles and Market Currents by email alert.
Get email alerts on MAKO »
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
5 Stocks To Trade, What's Next For The MarketThe Oxen Group • Tue, Oct 23, 2012 -
Pharma And Surgical Covered Call Trades With Attractive ReturnsDavid Sims • Wed, Oct 17, 2012 -
-
MAKO's CEO Discusses Q3 2012 Results - Earnings Call TranscriptWed, Nov 7, 2012
-
MAKO Surgical Corp. Q2 2010 Earnings Call TranscriptTue, Aug 3, 2010
-
MAKO Surgical Corp. Q1 2010 Earnings Call TranscriptMon, May 10, 2010
-
MAKO Surgical Corp. Q2 2008 Earnings Call TranscriptTue, Jul 29, 2008 • 3 Comments
-
GlobeNewswire (Jun 3, 2013)
-
GlobeNewswire (May 7, 2013)
-
GlobeNewswire (Apr 25, 2013)
-
GlobeNewswire (Apr 4, 2013)
-
GlobeNewswire (Mar 21, 2013)
-
GlobeNewswire (Mar 19, 2013)
-
GlobeNewswire (Feb 26, 2013)
-
MAKO Surgical Corp. Announces Appointment of Christopher R. Marrus as Senior Vice President of SalesGlobeNewswire (Feb 21, 2013)
-
GlobeNewswire (Jan 7, 2013)
-
at CNBC.com (Jan 3, 2013)
-
GlobeNewswire (Dec 19, 2012)
-
GlobeNewswire (Nov 19, 2012)
-
GlobeNewswire (Nov 16, 2012)
-
GlobeNewswire (Nov 14, 2012)
-
at CNBC.com (Nov 13, 2012)
-
GlobeNewswire (Nov 13, 2012)
-
GlobeNewswire (Nov 7, 2012)
MAKO vs. ETF Alternatives
Company Description
Currently, there's no company description for MAKO.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Tuesday, May 28, 2:34 PM Shares in Mako Surgical (MAKO +11.3%) move up today on heavy volume, pushing up towards the top of a channel its's traded in for most of this year after Wells Fargo ups their rating to Outperform from Market Perform. Wells thinks that MAKO’s new hip software for its RIO robot addresses concerns that have limited its adoption since launching in September 2011. The firm expects hip procedure growth, which represents a significantly large percentage of its projected revenue stream, should accelerate following the release of the software around July. Comment! [Healthcare, On the Move]
- Tuesday, May 28, 9:14 AM Premarket gainers: CSIQ +25%. PIP +21%. ROYL +17%. BGMD +11%. BLDP +11%. VRX +11%. SIGA +8%. TSL +8%. MAKO +8%. YGE +8%. CPST +8%. STSI +8%. HSOL +7%. ALU +7%. LDK +7%. JASO +7%. TIF +6%. Comment! [On the Move]
- Tuesday, April 9, 2:48 PM Mako Surgical (MAKO +4%) gains on an upgrade to Neutral by Mizuho Securities, raising it's price target from $12 to $14. Mizuho says that after being nearly halved over the past seven months due to growth concerns, consensus 2013 estimates are achievable. The company still has plenty of room for growth in uni-knees, the firm notes, even when you account for new robotics competitors. Comment! [Healthcare, On the Move]
-
Thursday, April 4, 5:47 PM
After-hours top gainers, as of 5:15 p.m.: WDFC +6%. MAKO +5%. CAJ +3%. SNTS +3%. OIBRC +2%.
After-hours top losers: NGD -7%. HMY -6%. CDE -6%. JNPR -5%. IAG -5%. Comment! [On the Move] - Wednesday, February 27, 12:42 PM Shares of Mako Surgical (MAKO +10.9%) surge despite a Q4 miss late yesterday, as the company forecasts higher sales of its RIO systems in the coming year with a corresponding 24% to 42% jump in surgical procedures. Comment! [Healthcare, Earnings, On the Move]
- Tuesday, February 26, 5:02 PM More on Mako Surgical (MAKO): Q4 misses across the board on an 8% decline in total sales Y/Y. For FY13, the company anticipates selling 45 to 48 RIO systems, versus a total of 45 RIO systems sold worldwide in 2012, and estimates its customers will perform 13,500 to 14,500 MAKOplasty procedures, versus 10,204 procedures performed in 2012. Shares +4.5 % AH. 3 Comments [Healthcare, On the Move, Earnings]
-
Thursday, January 17, 5:40 PM
After-hours top gainers, as of 5:15 p.m.: AM +9%. ARAY +4%. SOXS +3%. EGLE +3%. ONXX +2%.
After-hours top losers: COF -8%. TSRX -6%. PATH -5%. INTC -4%. MAKO -3%. Comment! [On the Move] - Monday, January 7, 9:59 AM MAKO Surgical (MAKO) -5.8% but recovering from earlier lows after saying that it sold 15 of its Rio surgical systems in Q4 and 45 in 2012, taking the total installed based to 156. The number of orthopedic MAKOplasty procedures performed +29% Y/Y to 2,904 in Q4. Sells 11 MAKOplasty Total Hip Arthroplasty (THA) applications, of which three were sold to existing customers. THA procedures performed +31% Q/Q. (PR) 1 Comment [On the Move, Healthcare]
- Monday, December 10, 2012, 2:49 PM Mako Surgical (MAKO -4.1%) falls after competitor Blue Belt Technologies received clearance from the FDA to market its NavioPFS orthopedic surgical system for partial knee replacement. MAKO markets its own device, called the RIO robotic system, which, although higher priced, offers some advantages in terms of implant availability, ease of use and broader applications in hips. Comment! [Healthcare, On the Move]
- Tuesday, November 20, 2012, 12:37 PM Shares of Mako Surgical (MAKO -1.2%) slip due to a post late yesterday on the FDA's website saying that MAKO had recalled its RIO System software, version 2.4 and is implementing software version 2.5 to address a functional issue with the existing version. Piper Jaffray says the recall had been previously disclosed, the issue looks minor and it shouldn't impact Q4 volumes. The firm reiterates an Overweight on the stock with a $28 price target. Comment! [Healthcare, On the Move]
- Wednesday, November 14, 2012, 11:38 AM Mako Surgical (MAKO +3.5%) is higher today after pricing its previously announced 3.042M share secondary offering at $13.15 per share, just a slight discount to its Tuesday close. The company anticipates net proceeds from the sale to be approximately $37M. Comment! [Healthcare, On the Move]
-
Thursday, November 8, 2012, 9:10 AM
Premarket gainers: DUSA +38%. MTSL +28%. USAT +15%. WLL +11%. ITMN +11%. SD +9%. QCOM +9%. THQI +8%. EZCH +7%. ALU +6%. MWW +7%. TTM +6%. DF +5%.
Losers: CPRX -56%. BCRX -34%. PANL -25%. SVNT -19%. SGEN -11%. MNST -10%. CNQR -9%. TNK -9%. NBG -8%. PSTI -8%. MAKO -7%. WINI -6%. AUI -5%. Comment! [On the Move] - Wednesday, November 7, 2012, 4:35 PM More on MAKO Surgical (MAKO): Q3 beats consensus on both EPS and revenue, but the company lowers its guidance for MAKOplasty procedures in Q4, based on the total procedures performed in the first three quarters of FY12 and the unknown net effect of Hurricane Sandy. It now expects to perform between 10,200 to 10,600 procedures, down from prior guidance of 11K to 12K. FY12 annual guidance of 42 - 48 expected RIO system sales remains unchanged. Shares -1.4% AH. Comment! [Healthcare, Earnings, On the Move]
- Wednesday, November 7, 2012, 4:15 PM Mako Surgical (MAKO): Q3 EPS loss of -$0.15 beats by $0.01. Revenue of $29M (+41% Y/Y) beats by $2M. Shares -1.8% AH. (PR) Comment! [Healthcare, Earnings, On the Move]
- Wednesday, September 5, 2012, 11:27 AM Mako Surgical (MAKO -1.3%) drifts lower after being initiated with a Market Perform at Wells Fargo, but with lackluster commentary and a less than impressive $15 - $17 price target range. The firm says there's reason for optimism over the long term in the name, but over the near term the ramp up of its new hip application product is likely to be slower than expected. 1 Comment [Healthcare, On the Move]
- Wednesday, August 29, 2012, 11:31 AM Shares of MAKO Surgical (MAKO +8.8%) trade up on the back of strong sales results from British supplier Corin Group (CNGHF.PK) overnight. Corin says H1 sales rose 15% to £25.0m, an increase of 13% on a constant currency basis, due in large part to heavy sales to MAKO. Traders are also speculating that a short squeeze might be underway as well, considering the company’s current trading float is over 30% short. Comment! [Healthcare, On the Move]
-
- View all 0 replies
-
- View all 0 replies
-
- View all 2 replies
-
Ferrari321: In line quarter - about 700K in one-time items. Outlook same ... shouldn't have an impact to the stock
-
-
- View all 10 replies
-
Noreika: I'm just gonna keep holding a few shares and see what happens. Not adding or selling. Seeing the pop was nice though this morning.. -
-
The Wall Street Transcript
MAKO Surgical Corp. ($MAKO) a Robotic-Surgery Story that Aligns with Future Health Care Economics- http://su.pr/1FYVZa - View all 0 replies
-
- View all 1 replies
-
-
- View all 0 replies
-
- View all 0 replies
-
- View all 8 replies
-
-
-
Ferrari321
$MAKO starting to form base - cup and handle pattern in play I think ... today's vol more than 3x average. Very bullish candle - View all 0 replies
LATEST REPLIES
-
- View all 2 replies
-
Ferrari321: In line quarter - about 700K in one-time items. Outlook same ... shouldn't have an impact to the stock
-
-
- View all 19 replies
-
-
John Motyka: jhogg; MAKO won recent patent infringement litigation. Question seems to be how many new RIO systems they can sell. $ tight for cap invests.
-
- View all 10 replies
-
Noreika: I'm just gonna keep holding a few shares and see what happens. Not adding or selling. Seeing the pop was nice though this morning..
-
-
- View all 8 replies
-
-
-
- View all 1 replies
-
-
Alan Brochstein
$MAKO - We are LONG at 11.20 on Marketfy:http://bit.ly/ZAE2Cf Almost stopped out yesterday... - View all 2 replies
-
-
Alan Brochstein: Not at marketfy - that's what I was referring to... We put on a ST Trade recently. In my Top 20 Model Portfolio, we have scaled down
-
Alan Brochstein
$MAKO - not sure if someone KNOWS or there is just FEAR, but stay tuned, as company likely pre-announcing on Monday before JPM conference - View all 6 replies
-
The Fox: I think the only good news was how hard it bounced off $10.30ish. It recovered well, but the news wasn't great (not terrible either).
-
Alan Brochstein: If I had to guess with an advance copy of the press release, I would have bet short-covering, so I would have been wrong
-
- View all 3 replies
-
johnbarleycorn: Perhaps patients/doctors worry that a partial knee operation (of the bad part) will only end up in a full knee operation later... -
johnbarleycorn: Though I would consider prolotherapy before any joint operation...
-
- View all 10 replies
-
-
-
FortSumter
$ABMD $MAKO Ugly. Two stocks I like for changing demographics but seems no one else does. No position.....yet. - View all 1 replies
-
nsahbti: MAKO to volatile and if I am correct they have no money. I would also like to see more data and some kind of outlook.
-
John Motyka
MAKO beats but gets caught in market down draft. As usual, perversity trumps the rational outcome and expectations of MAKO fans...jdm - View all 5 replies
-
FortSumter: Ouch. Down 10% on a stock offering after hours. Staying away from this name. Mgmt has issues, I think.
-
John Motyka: Fort: You are correct to stay away. Too late for me. I might as well take capital loss next year...jdm (sigh)
-
John Motyka
Longshots include ARCI, GERN, MAKO and MITK. Study up and lay your bets down on their futures...jdm - View all 6 replies
-
FortSumter: John - I do not. From what I understand MAKO is mainly in the west? Is there anybody else besides ISRG that does what they do?
-
John Motyka: Sumter: Some big boys working on prototypes, but ISRG first to market. The $ for these systems is in hardware and commissions per procedure.
-
- View all 3 replies
-
John Motyka: Fort: Its all about quarter to quarter earnings. For MAKO, they must sell more system units or die...jdm
-
-
- View all 2 replies
-
The Fox: Alan...you will be disappointed. Even if they hit their numbers management will blow the conference call. Ever listened to one? Incompetent
-
-
- View all 2 replies
-
-
Master Che: you're welcome..feel free to request updates on particular stocks